LOGIN
PeerView
You are viewing the most viewed ACE Reports by Sports Medicine Specialists over the last 30 days in all specialties.
Displaying
100%
5%
①
Synopsis:
One hundred and nineteen patients with insertional Achilles tendinopathy were randomized to received extracorporeal shockwave therapy with eccentric exercise (ESWT +EE) (n=58) or eccentric exercise (EE) and sham therapy (n=61).The primary outcome was function measured by the Victorian Institute of Sports Assessment-Achilles questionnaire (VISA-A).Secondary outcomes of interest included pain scores, the Foot and Ankle Outcome Score (FAOS), the Short Form Health Survey (SF-12), recurrence and failure of treatment.Both groups demonstrated significant improvements from baseline.No differences in the VISA-A, FAOS or SF-12 were found at any time point between groups. The EWST+EE group...
Read More »
Level 1 RCT
5%
①
Synopsis:
192 patients with unilateral, symptomatic knee osteoarthritis were randomized to receive 3 weekly intra-articular injections of leukocyte-rich platelet-rich plasma (n=96) or leukocyte-poor platelet-rich plasma (n=96).The primary outcome of interest was the International Knee Documentation Committee (IKDC) score at 12 months.Secondary outcomes of interest included the Knee Injury and Osteoarthritis Outcomes Score (KOOS) sub-scales, the Tegner scale for activity/sporting level, and Euro-QoL Visual Analog Scale (EQ-VAS) for quality of life. No significant differences...
Read More »
Level 1 RCT
3%
①
Synopsis:
One hundred five patients with clinically diagnosed knee osteoarthritis were randomized to receive a 6-week internet-based exercise and education program (n=48) or routine self-management care (n=57).The primary outcome of interest was change in self-reported knee pain using a numerical rating scale at 6 weeks.Secondary outcomes included physical function tests (30-second sit-to-stand, Timed Up-and-Go), WOMAC subscales (pain, stiffness, physical function), muscle strength, and quantitative sensory testing.Outcomes were assessed at baseline and 6 weeks.Overall, the results of the study revealed a significantly greater improvement in pain, function, and hamstring strength in the internet-based intervention group compared to usual care. These findings suggest...
Read More »
Level 1 RCT
2%
Improved Pain & Function With 8 Weeks of Electroacupunture or Manual Acupuncture vs Sham for Knee OA
①
Synopsis:
Four hundred and eighty patients diagnosed with knee osteoarthritis (OA) were randomized to receive electroacupuncture (EA; n=160) or manual acupuncture (MA; n=160) or sham (n=160) for a total of 8 weeks, 3 times/week.The primary outcome of interest was the response rate which consisted of patients improving at least 2 points on the numeric rating scale (NRS) for pain and 6 points on the WOMAC function subscale.Secondary outcomes of interest included the following: NRS pain at weeks 4, 16, and 26; WOMAC function at weeks 4, 16, and 26; WOMAC pain; WOMAC stiffness; quality of life using the 12-item Short Form (SF-12) health survey (i.e., mental health and physical health); incidence of paracetamol; and patient’s global assessment (PGA).WOMAC stiffness, SF-12 , and PGA scores were measured at 4, 8, 16, and 26 weeks follow-up.Also, incidence of adverse events were reported.Results revealed that the response rate, at 8 weeks, was statistically significantly higher in the EA compared to sham (n=0.023) but this was not observed when comparing MA to sham (n=0.051).Furthermore, the response rate at 4, 16, and 26 weeks follow-up was statistically significantly favored in the EA vs sham group but this was observed for MA vs sham only at weeks 16 and 26 (p<0.05).The total incidence of adverse events included 18, 22, and 17 patients in the EA, MA, and sham groups, respectively.NRS scores were statistically significantly improved in the EA vs Sham and MA vs sham groups for all timepoints.WOMAC function and pain were statistically significantly improved in the EA vs sham for all timepoints; yet, for WOMAC function, MA vs sham was only statistically significantly improved at 16 weeks follow-up (p<0.05).For WOMAC pain, a statistical significant improvement in scores was observed for weeks 8,16, and 26 (p<0.05).Moreover, WOMAC stiffness did not statistically significantly differ in MA vs sham groups for all timepoints, but EA vs sham was statistically improved at weeks 8 and 26 (p<0.05).For SF-12 physical health, a statistical significant improvement for EA and MA when compared to sham were observed only at 16 weeks follow-up (p=0.009 for EA vs sham; p=0.026 for MA vs sham).Finally, SF-12 mental health scores statistically significantly favored the EA compared to sham group only at week 26 (p=0.01) whereas MA was favored at both weeks 16 and 26 compared to sham (p=0.024; p=0.001, respectively). Finally, 4, 2...
Read More »
Level 1 RCT
2%
①
Synopsis:
84 patients over 18 years of age with isolated rib fractures were included in this single center, prospective, placebo controlled, double blind trial.Patients were randomly allocated to receive either 10% lidocaine spray (LS; n=29), etofenamate spray (ES; n=28) or placebo spray (PS; n=27).The primary outcome of interest was pain intensity measured using a numerical rating scale (NRS) at baseline, and 15, 30, 60 and 120 minutes.Other outcomes of interest included rescue medication requirements and adverse events.Study findings suggest that all three groups demonstrated similar NRS scores, with no significant difference in pain reduction found at any timepoint.The maximum reduction was seen in the LS group between baseline and 120 minutes, however this difference was not statistically significant.It was also seen that the need for rescue medication was lowest in the LS group; a difference that was found to be clinically significant but not statistically significant. Importantly, only one...
Read More »
Author verified Level 1 RCT
2%
①
Synopsis:
80 patients with distal radius fractures were randomized to receive either a 4-week (n=40) or a 6-week immobilization program.The primary outcome of interest was Quick Disabilities of the Arm, Shoulder, and Hand (QuickDASH) scores at one year.Secondary outcomes of interest included QuickDASH scores at 3 and 6 months, incidence of adverse events, and range of motion in radial and ulnar deviation, dorsiflexion, and palmar flexion.All outcomes were comparable between the two groups at all time points. Therefore, a shorter...
Read More »
Level 1 RCT
2%
①
Synopsis:
Five randomized controlled trials (189 patients) comparing platelet-rich plasma (PRP) against conservative treatment for chronic Achilles tendinopathy were included in this systematic review and meta-analysis.Outcomes of interest included the Victorian Insitute of Sport Assessment (VISA-A) score, pain during activity on a Visual Analog Scale (VAS), and Achilles tendon thickness.VISA-A scores at 6 weeks favored the PRP group.Tendon thickness also favored the PRP group. All other outcomes...
Read More »
Level 1 Meta Analysis
2%
②
Synopsis:
106 patients with adhesive capsulitis were randomized to one of three groups to determine which mode of conservative therapy - corticosteroid injections with distension, corticosteroid injections only, or treatment-as-usual (verbal education, use of other conservative therapy) - was associated with the greatest improvement in shoulder pain, function, and range of motion on the short-term (4 and 8 weeks) and long-term (12 months).Results demonstrated that patients in both corticosteroid injection intervention groups had significant improvements in pain, function, abduction, internal rotation, and external rotation when compared to the usual treatment group when assessed at 4 and 8 weeks. Long-term improvements in...
Read More »
Level 2 RCT
2%
①
Synopsis:
Two hundred forty patients with chronic midportion Achilles tendinopathy were randomized to receive either a single platelet-rich plasma (PRP) injection (n=121) or a sham subcutaneous dry needle injection (n=119).The primary outcome was the VISA-A score at 6 months, which assesses pain, function, and activity limitations related to Achilles tendinopathy.Secondary outcomes included the VISA-A score at 3 months, pain via visual analog scale (VAS), and health-related quality of life using EQ-5D-5L at multiple follow-up points (2 weeks, 3 months, and 6 months).Overall, the results of the study revealed no significant difference between the PRP and sham groups in any of the measured outcomes, including the primary VISA-A score at 6 months. These findings suggest...
Read More »
Level 1 RCT
2%
①
Synopsis:
12,211 patients from 21 trauma centers in the United States and Canada were included in this non-inferiority randomized trial comparing aspirin (n=6,101) and low molecular-weight heparin (n=6110).The primary outcome of interest was death by any cause at 90 days.Secondary outcomes of interest included the risk of thromboembolic events (pulmonary embolism; deep-vein thrombosis), cause-specific death, bleeding & wound complications, and the rate of infection.Aspirin was found to be non-inferior to low molecular-weight heparin with respect to the primary outcome of death by any cause. No differences in...
Read More »
Level 1 RCT